Ruth Foley[Author] - Search Results

Year	Number of Results
2004	2
2006	1
2009	2
2010	2
2011	3
2016	1
2017	1
2021	3
2022	2
2023	3
2024	0

1

Moran EM, Foley R, Powell FC. Moran EM, et al. Among authors: foley r. Clin Dermatol. 2017 Mar-Apr;35(2):195-200. doi: 10.1016/j.clindermatol.2016.10.014. Epub 2016 Oct 27. Clin Dermatol. 2017. PMID: 28274359

2

Gene-based therapy in prostate cancer.

Foley R, Lawler M, Hollywood D. Foley R, et al. Lancet Oncol. 2004 Aug;5(8):469-79. doi: 10.1016/S1470-2045(04)01525-6. Lancet Oncol. 2004. PMID: 15288235 Review.

3

Branch Unit Distribution Matters for Gene Delivery.

Li Y, He Z, Wang X, Li Z, Johnson M, Foley R, Sigen A, Lyu J, Wang W. Li Y, et al. Among authors: foley r. ACS Macro Lett. 2023 Jun 20;12(6):780-786. doi: 10.1021/acsmacrolett.3c00152. Epub 2023 May 23. ACS Macro Lett. 2023. PMID: 37220212 Free PMC article.

4

Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation.

Foley RA, Sims RA, Duggan EC, Olmedo JK, Ma R, Jonas SJ. Foley RA, et al. Front Bioeng Biotechnol. 2022 Sep 26;10:973326. doi: 10.3389/fbioe.2022.973326. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36225598 Free PMC article. Review.

5

Reactive oxygen species (ROS): utilizing injectable antioxidative hydrogels and ROS-producing therapies to manage the double-edged sword.

He Z, Xu Q, Newland B, Foley R, Lara-Sáez I, Curtin JF, Wang W. He Z, et al. Among authors: foley r. J Mater Chem B. 2021 Aug 28;9(32):6326-6346. doi: 10.1039/d1tb00728a. Epub 2021 Jul 25. J Mater Chem B. 2021. PMID: 34304256 Review.

6

Androgen hypersensitivity in prostate cancer: molecular perspectives on androgen deprivation therapy strategies.

Foley R, Marignol L, Keane JP, Lynch TH, Hollywood D. Foley R, et al. Prostate. 2011 Apr;71(5):550-7. doi: 10.1002/pros.21266. Epub 2010 Oct 13. Prostate. 2011. PMID: 20945429 Review.

7

Clinical potential of gene-directed enzyme prodrug therapy to improve radiation therapy in prostate cancer patients.

Vajda A, Marignol L, Foley R, Lynch TH, Lawler M, Hollywood D. Vajda A, et al. Among authors: foley r. Cancer Treat Rev. 2011 Dec;37(8):643-54. doi: 10.1016/j.ctrv.2011.03.003. Epub 2011 Apr 9. Cancer Treat Rev. 2011. PMID: 21481534 Review.

8

Non-viral delivery of CRISPR-Cas9 complexes for targeted gene editing via a polymer delivery system.

O'Keeffe Ahern J, Lara-Sáez I, Zhou D, Murillas R, Bonafont J, Mencía Á, García M, Manzanares D, Lynch J, Foley R, Xu Q, Sigen A, Larcher F, Wang W. O'Keeffe Ahern J, et al. Among authors: foley r. Gene Ther. 2022 Apr;29(3-4):157-170. doi: 10.1038/s41434-021-00282-6. Epub 2021 Aug 6. Gene Ther. 2022. PMID: 34363036 Free PMC article.

9

The emerging roles of DNA methylation in the clinical management of prostate cancer.

Perry AS, Foley R, Woodson K, Lawler M. Perry AS, et al. Among authors: foley r. Endocr Relat Cancer. 2006 Jun;13(2):357-77. doi: 10.1677/erc.1.01184. Endocr Relat Cancer. 2006. PMID: 16728568 Review.

10

Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease.

Foley R, Hollywood D, Lawler M. Foley R, et al. Endocr Relat Cancer. 2004 Sep;11(3):477-88. doi: 10.1677/erc.1.00699. Endocr Relat Cancer. 2004. PMID: 15369449 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year